Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Form 8-K

sec.gov

8-K — SRx Health Solutions, Inc.

Accession: 0001493152-26-017736

Filed: 2026-04-17

Period: 2026-04-17

CIK: 0001471727

SIC: 2080 (BEVERAGES)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex99-1_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0001471727

0001471727

2026-04-17

2026-04-17

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): April 17, 2026

SRx

Health Solutions, Inc.

(Exact

name of Registrant as Specified in its Charter)

Delaware

001-40477

83-4284557

(State

or other Jurisdiction

of

Incorporation)

(Commission

File

Number)

(IRS

Employer

Identification

No.)

801

US Highway 1

North

Palm Beach, Florida 33408

(Address

of Principal Executive Offices) (Zip Code)

(Registrant’s

Telephone Number, Including Area Code): (212) 896-1254

N/A

(Former

name or former address, if changed since last report.)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, $0.001 par value share

SRXH

NYSE

American

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☐

If

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

7.01. Regulation FD Disclosure

On

April 17, 2026, the SRx Health Solutions, Inc. (the “Company”) issued a press release updating its stockholders regarding

the progress on its previously announced transaction with EMJ Crypto Technologies Inc. (“EMJC”) A copy of the press

release is attached as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by reference.

The

information in Item 7.01 of this Current Report shall not be deemed to be “filed” for the purposes of Section 18 of the Securities

and Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section,

nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange

Act, except as shall be expressly set forth by specific reference in such a filing.

Forward-Looking

Statements

This

current report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section

21E of the Exchange Act, which are intended to be covered by the “safe harbor” created by those sections. All statements

in this current report that are not based on historical fact are “forward looking statements.” These statements may be identified

by words such as “estimates,” “anticipates,” “projects,” “plans,” “strategy,”

“goal,” or “planned,” “seeks,” “may,” “might”, “will,” “expects,”

“intends,” “believes,” “should,” and similar expressions, or the negative versions thereof, and which

also may be identified by their context. All statements that address operating performance or events or developments the Company expects

or anticipates will occur in the future, such as stated objectives or goals, refinement of strategy, attempts to secure additional financing,

exploring possible business alternatives, or that are not otherwise historical facts, are forward-looking statements. While management

has based any forward-looking statements included in this current report on its current expectations, the information on which such expectations

were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ

materially from those in the forward-looking statements as a result of various factors, including risks associated with the Company’s

ability to obtain additional capital in the future, the proposed transaction with EMJC, general economic factors, competition in the

industry and other factors that could cause actual results to be materially different from those described herein as anticipated, believed,

estimated or expected. Additional risks and uncertainties are described in or implied by the Risk Factors and Management’s Discussion

and Analysis of Financial Condition and Results of Operations sections of the Company’s 2025 Annual Report on Form 10-K, filed

on February 13, 2026 and other reports filed from time to time with the Securities and Exchange Commission (“SEC”).

The Company urges you to consider those risks and uncertainties in evaluating its forward-looking statements. Readers are cautioned to

not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required

by the federal securities laws, the Company disclaims any obligation or undertaking to publicly release any updates or revisions to any

forward-looking statement contained herein (or elsewhere) to reflect any change in its expectations with regard thereto, or any change

in events, conditions, or circumstances on which any such statement is based.

Item

9.01. Financial Statements and Exhibits.

(d) Exhibits.

Exhibits

Description

99.1

Press Release, dated April 17, 2026.

104

Cover

Page Interactive Data File (Embedded within the Inline XBRL document)

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

SRx

Health Solutions, Inc.

By:

/s/

Carolina Martinez

Name:

Carolina

Martinez

Title:

Chief

Financial Officer

April

17, 2026

EX-99.1

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

SRx

Health Solutions and EMJX Issue Letter to Shareholders from Eric M. Jackson

EMJ

Crypto Technologies (EMJX) Founder and CEO Mr. Jackson provides update on operational progress and timing of proposed merger between

SRx Health Solutions and EMJX

NORTH

PALM BEACH, FL — April 17, 2026 — SRx Health Solutions, Inc. (NYSE American: SRXH) (the “Company”) and EMJ

Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the Company has entered into a definitive

merger agreement, today released a letter to shareholders providing an update on the proposed transaction from Eric. M. Jackson, the

creator of the EMJX platform. Mr. Jackson will be appointed as an officer of the Company’s EMJC subsidiary following the merger.

Dear

Shareholders,

I

wanted to take this opportunity to provide an update on our latest progress and the merger agreement between the Company and EMJX. As

most of you are aware, the Company entered into a definitive agreement to acquire EMJX, the next-generation (“Gen2”) digital-asset

treasury platform I founded.

I

have spent over 20 years in public markets, most recently running EMJ Capital, with a PhD in Management from Columbia Business School.

I can sincerely say I am excited about the opportunity we have with this transaction to drive value for shareholders.

Operational

Progress in 2026

Since

announcing this merger in December 2025, we’ve made substantial operational progress. First, we deployed $18 million into our second-generation

digital asset treasury hedging strategy, delivering a 5.69% return in March 2026 compared to a 4.98% decline in the S&P 500 index

amid ongoing global uncertainty. This amounts to a 10.67% outperformance over the S&P 500 during this period. Through mid-April,

we achieved approximate gains of 3.5% and 8% in our hedging pool and long treasury investment holdings, respectively. Second, we’ve

been engaging in business development and market education discussions across the U.S. investment community and businesses, showcasing

the institutional capabilities of our platform.

These

past few months have laid the groundwork for EMJX’s future. We’ve proven out our operating system, which applies quantitative

models, artificial intelligence, and systematic risk controls to multi-asset digital treasury management. We believe this Gen2 framework

reflects the continued maturation of digital-asset treasuries toward more disciplined, institutional-grade capital management models.

What

we have brought to market is structurally different to what we have typically seen in history: Gen1 treasury approaches that rely on

price appreciation of a single asset and typically lack systematic risk management, exposing shareholders to significant drawdowns and

dilution during adverse market conditions. In contrast, our Gen2 approach is structured as a platform that governs how capital is allocated,

hedged, and reinvested across market cycles, rather than functioning as a passive balance sheet tracking asset values. This distinction

is important because for EMJX, we have spent a lot of time focusing on governance and rules to build a system based on intelligence.

In essence, EMJX is a treasury operating system - not a fund, nor crypto fund, nor a hedge fund, but something built to last.

As

we look forward, we have been focused on expanded treasury deployment to areas we believe have high growth potential. Just yesterday,

the Company announced it had acquired shares in the open market of Compass Inc. and increased its investment in Opendoor Technologies

Inc.

Update

on Timing

I

understand that complex corporate transactions like this can create uncertainty, but I want to reiterate my confidence in this deal and

its ability to propel our business and deliver long-term shareholder value.

This

week, the Company filed a registration statement on Form S-4 with the SEC for this important transaction. SRXH’s Board of

Directors and EMJX are committed to maximizing shareholder value through this transaction and structuring the post-merged company in

a way that best aligns with all shareholders. Now that the S-4 is filed, we will undergo a regulatory review period – a typical

process for this type of transaction – and, pending approval, we will then be cleared to close. We are following the clear process

as laid out by the SEC, but hope to conclude this as soon as possible.

Upon

completion, the EMJX platform will operate through a wholly-owned subsidiary of the Company. As Founder of EMJX, I am proud of the performance

that it is delivering so far and I am thrilled to show what we can do in the future.

To

close, I want to thank you, as shareholders, for your continued support and patience. We look forward to providing further updates in

the future.

Regards,

Eric.

M. Jackson

EMJX

Founder & Chief Executive Officer

Additional

Information and Where to Find It

In

connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on Form S-4 (the “Registration

Statement”) to register the common stock to be issued in connection with the proposed transaction. The Registration Statement includes

an information statement of the Company and a prospectus of the Company (the “Information Statement/Prospectus”), and each

of EMJX and the Company may file with the SEC other relevant documents concerning the proposed transaction. After the Registration Statement

is declared effective, the definitive Information Statement/Prospectus will be sent to the stockholders This is not a substitute for

the Registration Statement, the Information Statement/Prospectus or any other relevant documents that EMJX or the Company has filed or

will file with the SEC. BEFORE MAKING ANY INVESTMENT DECISION, INVESTORS AND STOCKHOLDERS OF THE COMPANY ARE URGED TO CAREFULLY AND ENTIRELY

READ THE REGISTRATION STATEMENT AND INFORMATION STATEMENT/PROSPECTUS REGARDING THE PROPOSED TRANSACTION AND ANY OTHER RELEVANT DOCUMENTS,

AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, IF AND WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION

ABOUT EMJX, THE COMPANY, THE PROPOSED TRANSACTION, AND RELATED MATTERS. A copy of the Registration Statement, Information Statement/Prospectus,

as well as other relevant documents filed by EMJX and the Company with the SEC, may be obtained free of charge, when they become available,

at the SEC’s website at www.sec.gov. The information on EMJX’s or the Company’s respective websites is not, and shall

not be deemed to be, a part of this communication or incorporated into other filings either company makes with the SEC.

No

Offer or Solicitation

This

communication is for informational purposes only and is not intended to and does not constitute an offer to sell or the solicitation

of an offer to buy or sell any securities or the solicitation of any proxy, vote or approval, nor shall there be any sale of securities

in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities

laws of any such jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section

10 of the Securities Act, or in a transaction exempt from the registration requirements of the Securities Act.

Forward-Looking

Statements

This

press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such

as “believe,” “expect,” “intend,” “aim,” “plan,” “may,” “could,”

“target,” and similar expressions are intended to identify forward-looking statements. These statements are based on current

expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those

expressed or implied. These risks include, but are not limited to, the ability to complete the proposed transaction, shareholder approvals,

market conditions, regulatory considerations, and other risks described in the Company’s filings with the Securities and Exchange

Commission. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to update them, except

as required by law.

Company

Contact

SRx

Health Solutions, Inc.

Kent

Cunningham, Chief Executive Officer

Investor

Relations Contact

KCSA

Strategic Communications

Valter

Pinto, Managing Director

212-896-1254

valter@kcsa.com

GRAPHIC

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 3

Binary file (2110 bytes)

Download ex99-1_001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Apr. 17, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Apr. 17, 2026

Entity File Number

001-40477

Entity Registrant Name

SRx

Health Solutions, Inc.

Entity Central Index Key

0001471727

Entity Tax Identification Number

83-4284557

Entity Incorporation, State or Country Code

DE

Entity Address, Address Line One

801

US Highway 1

Entity Address, City or Town

North

Palm Beach

Entity Address, State or Province

FL

Entity Address, Postal Zip Code

33408

City Area Code

(212)

Local Phone Number

896-1254

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, $0.001 par value share

Trading Symbol

SRXH

Security Exchange Name

NYSEAMER

Entity Emerging Growth Company

false

X

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

na

Period Type:

duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

na

Period Type:

duration

X

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

na

Period Type:

duration